Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Melodiol Global Health Ltd (OP: COPHF )

N/A UNCHANGED
Last Price Updated: 9:31 AM EDT, Apr 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Melodiol Global Health Ltd

Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More
Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research 
Via Benzinga
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
Australia-based cannabis and psychedelics company Creso Pharma Ltd. (OTCMKTS: COPHF) inked a Letter of Intent (LOI) with Swiss pharmacy Apotheke Dr. 
Via Benzinga
Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings
Cannabis company Creso Pharma (OTCMKTS: COPHF)’s wholly-owned psychedelics subsidiary Halucenex Life Sciences Inc. 
Via Benzinga
KGK Sciences And Halucenex Sign Contract For Phase II Clinical Trial On Psilocybin For PTSD
KGK Sciences Inc., a subsidiary company of psychedelics healthcare researcher and provider Wellbeing Digital Sciences Inc. 
Via Benzinga
Australian Creso Pharma To Enter US CBD Market Via $21M Acquisition Of Sierra Sage Herbs
Cannabis company Creso Pharma Limited (ASX: CPH) (OTC: COPHF) (FRA:1X8) is entering the US CBD market, following a purchase agreement to acquire Colorado-based consumer packaged... 
Via Benzinga
Cannabis Movers & Shakers: Akerna, iAnthus, Cronos Group, WSU's Cannabis Research Center
Akerna Taps Current COO Ray Thompson As President & COO Akerna Corp (NASDAQ: 
Via Benzinga
Cronos Promotes John Griese, Former Exec At Nestlé, PepsiCo And Supreme Cannabis
Canadian cannabis company Cronos Group (NASDAQ:CRON) promot... 
Via Benzinga
Psyched: Field Trip Gets $20 Price Target, DEA Seeks To Increase Psilocybin Production Limits, Synthesis Closes $7.25M Series A
Contents 
Via Benzinga
Red Light Holland and Creso Pharma Call Off Psilocybin-Cannabis Merger
“Magic mushroom” company Red Light Holland (CSE:TRIP 
Via Benzinga
Red Light Holland and Creso Pharma Agree to Terminate Merger
Toronto, Ontario--(Newsfile Corp. - August 30, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red... 
Via Newsfile
Topics Cannabis
Exposures COVID-19 Cannabis
Billion Dollar Company Creators Bruce Linton of Canopy Growth $CGC & Dr. Halperin of MindMed $MMED Created Newco $COPHF
2 Billion Dollar Company Creators Bruce Linton from Canopy Growth $CGC is an Advisor and Dr. Halperin from MindMed $MMED Created $COPHF! 
Via EIN Presswire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Red Light Holland Provides Initial FAQ in connection with Transaction with Creso Pharma
Toronto, Ontario--(Newsfile Corp. - June 21, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red... 
Via Newsfile
Topics Cannabis
Exposures COVID-19 Cannabis
Red Light Holland to Host a Live Stream on the Company's Social Media Handles, Including www.youtube.com/redlightholland at 8:30 am Eastern Time on Thursday, June 17th to Discuss Previously Announced Merger with Creso Pharma and Formation of the HighBrid
Toronto, Ontario--(Newsfile Corp. - June 16, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red... 
Via Newsfile
Topics Cannabis
Exposures COVID-19 Cannabis
Creso Pharma and Red Light Holland Merge to Introduce The HighBrid Lab (TM), a Leading Global Psychedelics x Cannabis Company, Specializing in Recreational Products, Applied Science, Technology and Innovation
● Creso Pharma and Red Light Holland have entered into a definitive agreement... 
Via Newsfile
Topics Cannabis Intellectual Property
Exposures COVID-19 Cannabis Intellectual Property
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.